Concepedia

TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients

Maya Dadiani, Daniela Necula, Smadar Kahana‐Edwin, Nino Oren, Tamir Baram, Irina Marin, Dana Morzaev‐Sulzbach, Anya Pavlovski, Nora Balint‐Lahat, Liat Anafi,

Cancer Immunology Immunotherapy · 2020 · 15 citations · 38 references

DOIFull text

Open access

Concepts

References

38

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

Christina Curtis, Sohrab P. Shah, Suet‐Feung Chin et al. · Nature · 2012 · 6.4K citations · Full text

, , +14

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Peter Schmid, Sylvia Adams, Hope S. Rugo et al. · New England Journal of Medicine · 2018 · 4.4K citations · Full text

, , +17

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Roberto Salgado, Carsten Denkert, Sandra Demaria et al. · Annals of Oncology · 2014 · 3.1K citations · Full text

, , +16

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

Sherene Loi, Damien Drubay, Sylvia Adams et al. · Journal of Clinical Oncology · 2019 · 891 citations · Full text

, , +17

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings et al. · Nature Medicine · 2019 · 889 citations · Full text

, , +17